3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase

Jing Tang, Kasthuraiah Maddali, Mathieu Metifiot, Yuk Y. Sham, Robert Vince, Yves Pommier, Zhengqiang Wang

Research output: Contribution to journalArticlepeer-review

48 Scopus citations


Integrase (IN) represents a clinically validated target for the development of antivirals against human immunodeficiency virus (HIV). Inhibitors with a novel structure core are essential for combating resistance associated with known IN inhibitors (INIs). We have previously disclosed a novel dual inhibitor scaffold of HIV IN and reverse transcriptase (RT). Here we report the complete structure-activity relationship (SAR), molecular modeling, and resistance profile of this inhibitor type on IN inhibition. These studies support an antiviral mechanism of dual inhibition against both IN and RT and validate 3-hydroxypyrimidine-2,4-diones as an IN inhibitor scaffold.

Original languageEnglish (US)
Pages (from-to)2282-2292
Number of pages11
JournalJournal of medicinal chemistry
Issue number7
StatePublished - Apr 14 2011


Dive into the research topics of '3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase'. Together they form a unique fingerprint.

Cite this